Skip to Content
Merck

138576

1-Adamantylamine

97%

Synonym(s):

1-Aminoadamantane

Sign In to View Organizational & Contract Pricing.

Select a Size

All Photos(5)

About This Item

Empirical Formula (Hill Notation):
C10H17N
CAS Number:
768-94-5
Molecular Weight:
151.25
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
24848359
EC Number:
212-201-2
Beilstein/REAXYS Number:
2204333
MDL number:
MFCD00074732

Product Name

1-Adamantylamine, 97%

InChI key

DKNWSYNQZKUICI-CHIWXEEVSA-N

InChI

1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2/t7-,8+,9-,10-

SMILES string

NC12C[C@H]3C[C@H](C[C@H](C3)C1)C2

assay

97%

mp

206-208 °C (lit.)

solubility

1 M HCl: soluble 5%, clear to hazy, colorless to faint yellow or tan

Quality Level

200

Gene Information

human ... GRIN2A(2903)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

1-Adamantylaminecan be used as a reactant to synthesize:
  • Adamantyl ureas by reacting with isocyanates in the presence of triethylamine.
  • N-(1-adamantyl)-2-chloroacetamide from chloroacetyl chloride in the presence of potassium carbonate.

General description

1-Adamantylamine, also known as Amantadine, is an adamantane derivative where an amino group is replaced by one of the methyl groups of adamantane. It is commonly used as a starting material in various organic reaction, such as monomer synthesis and one-pot synthesis of 1-adamantylhydrazine.

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCW8663
MKCW8255
0000227068
MKCS5254
MKCT4661

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Márió Gajdács et al.
Antibiotics (Basel, Switzerland), 8(4) (2019-12-22)
Background: The emergence of multidrug-resistant organisms (MDROs) is a global public health issue, severely hindering clinicians in administering appropriate antimicrobial therapy. Drug repurposing is a drug development strategy, during which new pharmacological applications are identified for already approved drugs. From
Zari Hooshyar et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 173, 144-150 (2016-09-18)
In this study, we describe the synthesis of a new quantum dots (QDs) by embedding glutathione capped CdTe/ZnS QDs into cationic starch biopolymer (CS-GSH-CdTe/ZnS QDs). The fluorescence intensity of prepared QDs was significantly enhanced. When QDs interacted with rifampicin, the
Dinesh Addla et al.
Bioorganic & medicinal chemistry letters, 24(8), 1974-1979 (2014-04-01)
A series of novel 1,2,3-triazole-adamantylacetamide hybrids 5a-u, designed by combining bioactive fragments from antitubercular I-A09 and substituted adamantyl urea, were synthesized using copper catalyzed click chemistry. N-(1-Adamantyl)-2-azido acetamide 3 prepared from 1-adamantylamine was reacted with a series of alkyl/aryl acetylenes
Jinglun Huang et al.
The Journal of organic chemistry, 72(1), 204-208 (2006-12-30)
The enantioselective Strecker reaction of N-diphenylphosphinoyl ketoimines has been achieved by use of in situ prepared chiral N,N'-dioxide catalyst from l-piperidinamide 3f and m-chloroperoxybenzoic acid (m-CPBA). Excellent yields (up to 99%) and high enantioselectivities (up to 92% ee) were obtained.
Lei Deng et al.
Nature communications, 9(1), 359-359 (2018-01-26)
Current influenza vaccines provide limited protection against circulating influenza A viruses. A universal influenza vaccine will eliminate the intrinsic limitations of the seasonal flu vaccines. Here we report methodology to generate double-layered protein nanoparticles as a universal influenza vaccine. Layered
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service